Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embryonal rhabdomyosarcoma in adults.

R V Lloyd, S I Hajdu, W H Knapper

    Cancer
    |February 1, 1983
    PubMed
    Summary

    Adult embryonal rhabdomyosarcomas have a poor prognosis, with a 21% five-year survival rate. However, early-stage (Stage II) disease and multimodal treatment including surgery improved outcomes, with recent trends showing fewer recurrences and better survival.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Localization of vascular endothelial growth factor in nontumorous human pituitaries.

    Endocrine pathology·2016
    Same author

    Prevention of trauma-induced cochlear fibrosis using intracochlear application of anti-inflammatory and antiproliferative drugs.

    Neuroscience·2016
    Same author

    Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.

    Oncogene·2014
    Same author

    Pituitary blastoma: a unique embryonal tumor.

    Pituitary·2011
    Same author

    Identification and consequences of galectin-3 expression in pituitary tumors.

    Molecular and cellular endocrinology·2010
    Same author

    Silent subtype 3 carcinoma of the pituitary: a case report.

    Neuropathology and applied neurobiology·2009

    Area of Science:

    • Oncology
    • Pathology

    Background:

    • Embryonal rhabdomyosarcoma is a rare soft tissue sarcoma.
    • Adult cases present unique challenges compared to pediatric rhabdomyosarcoma.

    Purpose of the Study:

    • To analyze clinical characteristics and outcomes of adult embryonal rhabdomyosarcomas.
    • To identify prognostic factors and evaluate treatment modalities.

    Main Methods:

    • Retrospective review of 54 adult embryonal rhabdomyosarcoma cases.
    • Classification based on anatomic site, tumor size, histology, age, sex, and treatment.
    • Comparison of outcomes between different diagnostic periods (1950-1969 vs. 1970-1978).

    Main Results:

    • Overall five-year survival was 21%; 79% of patients died within 17 months.
    • Stage II disease (tumor size < 5 cm) had an 80% five-year survival rate.
    • Multimodal therapy including surgery yielded better results than radiation or chemotherapy alone.
    • Patients diagnosed between 1970-1978 showed improved survival, fewer recurrences, and less metastasis compared to 1950-1969.

    Conclusions:

    • Adult embryonal rhabdomyosarcoma remains a challenging diagnosis with a generally poor prognosis.
    • Early-stage disease and aggressive surgical management are critical for improved survival.
    • Advances in treatment strategies have led to better outcomes in recent decades.

    Related Experiment Videos